Dr Kevin Holden

Dr Kevin Holden

Head of Science and Applied Research

Synthego

United States

Delegate / Speaker

Presentations at CRISPR in Drug Discovery 2023

Wed8 Feb10:50am(15 mins)	Using arrayed CRISPR screening approaches and CRISPR engineered cell lines in the drug discovery process
	Session: Target Validation Room: Auditorium

Colleagues

Ms Monika Deucman

Senior Marketing Manager

Synthego

Germany

View Profile

Mr ARTUR GITTOS

Account Development Representative

Synthego

View Profile

Ms Zofia Świątczak

Strategic Account Manager

Synthego

United States

View Profile

Hosted By

ELRIG

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis

Get the App

Get this event information on your mobile by
going to the Apple or Google Store and search for 'myEventflo'

www.myeventflo.com/2471